{
  "bio": [
    "The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.",
    "The company is India's most valuable listed pharma outfit and gets two-thirds of its $5.3 billion annual revenue from overseas markets.",
    "He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.",
    "In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals."
  ],
  "about": [
    "Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.",
    "Shanghvi 's favorite cuisine is south Indian."
  ]
}